We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA, FDA to Increase Non-EU Site Inspections
EMEA, FDA to Increase Non-EU Site Inspections
February 18, 2009
The European Medicines Agency (EMEA) is planning to join the FDA in increasing the number of good clinical practice (GCP) inspections at clinical trial sites outside North America and Western Europe.